Investigation into the effect of RP11-543C4.3-001 on CYP46A1 expression, as well as its role in cholesterol metabolism and Aβ production, may provide more evidence and reveal a new target for the treatment of AD pathology. Here, CYP46A1 is linked to Alzheimer disease.